EMG Analysis in ABI: Motor Imagery and Action
Launched by UNIVERSITY OF SALAMANCA · Jan 19, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "EMG Analysis in ABI: Motor Imagery and Action," is studying how specific rehabilitation techniques can help stroke survivors improve their hand and arm movements. Researchers at the University of Salamanca want to see how two methods—Motor Imagery (thinking about moving) and Action Observation (watching others move)—affect muscle activity in the arms. By measuring how well the muscles in the wrist and fingers respond during these activities, the study aims to find out how these techniques can aid recovery and enhance the quality of life for those who have experienced a stroke.
To participate in the study, individuals need to be at least 18 years old and have had a stroke that has caused some weakness or difficulty in moving their arms. They should also be able to understand and follow instructions. However, those with certain mental health issues before their stroke, severe heart or lung problems, or other serious health conditions may not be eligible. Participants will take part in three sessions where their muscle activity will be measured, helping researchers learn more about effective ways to support recovery after a stroke. This research could lead to better rehabilitation practices in occupational and physiotherapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being over 18 years of age
- • Diagnoses of established stroke
- • Present limitations or motor response deficiencies in the upper limb
- • Maintain cognitive functions with the ability to follow the instructions of the interventions and evaluations (MOCA\>14)
- Exclusion Criteria:
- • Diagnosed with mental illness before the stroke
- • Other systemic conditions on the central nervous system
- • Cardiorespiratory system pathologies in severe cases
- • Acute period, fever, muscle inflammation or myopathies
- • Any type of vascular and organic insufficiency
- • Liver disease or skin lesions in the area of application of the electrodes.
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salamanca, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported